Alkermes plc (ALKS) Misses Q1 EPS by 10c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
Alkermes plc Reports First Quarter 2017 Financial Results
April 27, 2017 7:00 AM EDTFirst Quarter Revenues Increased 22% Year-Over-Year to $191.8 Million, GAAP Loss per Share of $0.45 and Non-GAAP Loss per Share of $0.18
VIVITROL® Net Sales Grew by 33% Year-Over-Year to $58.5 Million
ARISTADA® Gaining Traction in Growing Long-Acting Antipsychotic Market; Preparing for Launch of Two-Month Dose Following June 5, 2017 PDUFA Date
DUBLIN--(BUSINESS WIRE)-- Alkermes plc (NASDAQ:... More
